Miromatrix Medical Inc
NASDAQ:MIRO
Miromatrix Medical Inc
NASDAQ:MIRO
Price:
3.39 USD
Market Closed
Updated:
May 26, 2024
Section:
Relative Value
There is not enough data to reliably calculate the relative value of MIRO.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MIRO
Relative Value
Base Case
Not Available
Valuation Multiples
Multiples Across Competitors
MIRO Competitors Multiples
Miromatrix Medical Inc Competitors
Miromatrix Medical Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Miromatrix Medical Inc
NASDAQ:MIRO
|
93m USD | 96.8 | -3.4 | -2.8 | -2.7 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
222.9B USD | 5.2 | 36.9 | 23 | 33.7 | |
| US |
|
Danaher Corp
NYSE:DHR
|
194.6B USD | 4.5 | 24.1 | 17.5 | 21.6 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
44.1B USD | 6.6 | 35.7 | 28.5 | 34.3 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
41.7B USD | 2.8 | 30.7 | 16.7 | 25.8 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
37.2B CHF | 5.5 | 56.8 | 19.5 | 28.6 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
53.5T KRW | 13.6 | 59.7 | 31.2 | 45.7 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
31.6B USD | 8.3 | 40.6 | 27.7 | 30.8 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
26.5B USD | 3.2 | 38.8 | 17.5 | 26.8 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
24.2B USD | 8.3 | 42.6 | 29.5 | 35.8 | |
| US |
|
Waters Corp
NYSE:WAT
|
20B USD | 6.9 | 33.1 | 22.3 | 27.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
